Maria Düring

2.6k citations

23 papers · 2.1k indexed · 1 hit paper · h-index 13

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
- Diabetes Management and Research
Cancer Research top 5%
- Breast Cancer Treatment Studies

Papers in ⓘ

Cancer Research 11
- Breast Cancer Treatment Studies 9
Endocrinology, Diabetes and Metabolism 8
- Diabetes Treatment and Management 8

Co-authors: Kjeld Hermansen (7 shared papers)Michael A. Nauck (6 shared papers)Anders Frid (6 shared papers)David R. Matthews (4 shared papers)Tsvetalina Tankova (5 shared papers)Ismail Mitha (4 shared papers)Nalini S. Shah (2 shared papers)Milan Zdravković (2 shared papers)
Journals: Diabetes Obesity and Metabolism (3 papers)Journal of Clinical Oncology (3 papers)Canadian Journal of Diabetes (3 papers)British Journal of Cancer (2 papers)Acta Oncologica (2 papers)
Partner nations: Denmark United States United Kingdom

In The Last Decade

Maria Düring

23 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes 2008 · 939 citations

Peers

Countries citing papers authored by Maria Düring

Since Specialization

Citations

This map shows the geographic impact of Maria Düring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Düring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Düring more than expected).

Fields of papers citing papers by Maria Düring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Düring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Düring. The network helps show where Maria Düring may publish in the future.

Co-authors

The 25 scholars most cited alongside Maria Düring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maria Düring Line = papers co-authored together Maria Düring links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes Diabetes Care ·Michael A. Nauck, Anders Frid, Kjeld Hermansen, Nalini S. Shah, Tsvetalina Tankova, Ismail Mitha, Milan Zdravković, Maria Düring, David R. Matthews, (unknown) Hit paper breakdown →	2008	939
2	Weight loss with liraglutide, a once‐daily human glucagon‐like peptide‐1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue Diabetes Obesity and Metabolism ·Johan Jendle, Michael A. Nauck, David R. Matthews, Anders Frid, Kjeld Hermansen, Maria Düring, Marija Zdravković, Boyd J. Strauss, A. J. Garber, (unknown)	2009	247
3	Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol Acta Oncologica ·M Blichert-Toft, Maja Nielsen, Maria Düring, Susanne Möller, Fritz Rank, Marie Overgaard, Henning T. Mouridsen	2008	213
4	Prognostic effect of estrogen receptor status across age in primary breast cancer International Journal of Cancer ·N Bentzon, Maria Düring, Birgitte Rasmussen, Henning T. Mouridsen, Niels Kroman	2007	123
5	Long‐term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2‐year results from the LEAD ‐2 study Diabetes Obesity and Metabolism ·Michael A. Nauck, Anders Frid, Kjeld Hermansen, Anne Bloch Thomsen, Maria Düring, NS Shah, Tsvetalina Tankova, Ismail Mitha, David Matthews	2012	121
6	Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat‐rich meal in patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, cross‐over trial Diabetes Obesity and Metabolism ·Kjeld Hermansen, Tine A. Bækdal, Maria Düring, Anna Pietraszek, Lene Mortensen, Hanne Skou Jørgensen, Anne Flint	2013	116
7	Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG) British Journal of Cancer ·S. Cold, Maria Düring, Marianne Ewertz, Ann Knoop, Susanne Möller	2005	96
8	The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999 British Journal of Cancer ·Susanne Oksbjerg Dalton, Maria Düring, Lone Ross, Kathrine Carlsen, Preben Bo Mortensen, John Lynch, Christoffer Johansen	2006	70
9	Influence of socioeconomic factors on survival after breast cancer—A nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999 International Journal of Cancer ·Susanne Oksbjerg Dalton, Lone Ross, Maria Düring, Kathrine Carlsen, Preben Bo Mortensen, John Lynch, Christoffer Johansen	2007	64
10	Community-based study of the incidence of gastrointestinal diseases in The Netherlands Epidemiology and Infection ·A. Hoogenboom-Verdegaal, J.C. de Jong, Maria Düring, Rudolf T. Hoogenveen, J.A. Hoekstra	1994	51
11	Delayed Breast Reconstruction With Implants After Invasive Breast Cancer Does Not Impair Prognosis Annals of Plastic Surgery ·Lisbet Rosenkrantz Hölmich, Maria Düring, Trine Foged Henriksen, Christen Krag, Ulla Brix Tange, Kim Kjøller, Joseph K. McLaughlin, Jørgen H. Olsen, Søren Friis	2008	26
12	Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer British journal of surgery ·C. K. Axelsson, Maria Düring, Peer Christiansen, P Wamberg, Katrine Lydolph Søe, Susanne Möller	2008	18
13	Breast conserving treatment in Denmark, 1989–1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group. Acta Oncologica ·Marianne Ewertz, Mette Moe Kempel, Maria Düring, Maj‐Britt Jensen, Michael Andersson, Peer Christiansen, Niels Kroman, Birgitte Rasmussen, Marie Overgaard	2008	16
14	Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycem1c Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin. Canadian Journal of Diabetes ·Anders Frid, Michael A. Nauck, Kjeld Hermansen, Nalini S. Shah, Tsvetalina Tankova, Ismail Mitha, Maria Düring, Marija Zdravković, David R. Matthews	2008	12
15	Axillary staging during surgery for breast cancer British journal of surgery ·C. K. Axelsson, Henning T. Mouridsen, Maria Düring, Susanne Möller	2007	11
16	TOP2A aberrations as predictive and prognostic marker in high-risk breast cancer patients. A randomized DBCG Trial (DBCG89D) Journal of Clinical Oncology ·Ann Knoop, Helle Knudsen, Eva Balslev, Blake B. Rasmussen, Jens Overgaard, Maria Düring, Kirsten Vang Nielsen, Jesper Tranekjær Jørgensen, H.T. Mouridsen, Bent Ejlertsen	2006	10
17	The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial Nature Communications ·Jaume Mora, Gcf Chan, Daniel A. Morgenstern, Loredana Amoroso, Karsten Nysom, Jörg Faber, Arthur Wingerter, Melissa K. Bear, Alba Rubio‐San‐Simón, Blanca Martínez de las Heras, Karen Tornøe, Maria Düring, Brian H. Kushner	2025	3
18	Phase 1 trial of GD2-SADA:¹⁷⁷Lu-DOTA drug complex in patients with recurrent or refractory metastatic solid tumors known to express GD2 including small cell lung cancer (SCLC), sarcoma, and malignant melanoma. Journal of Clinical Oncology ·Taofeek K. Owonikoko, Justin C. Moser, Janet Yoon, Emily K. Slotkin, Afshin Dowlati, T. Vincent, Maria Düring, Joen Sveistrup	2023	3
19	Liraglutide, a Once-daily Human GLP-1 Analog, In Type 2 Diabetes Provides Similar Glycemic Control with Reduced Body Weight Compared with Glimepiride when Added to Metformin. Canadian Journal of Diabetes ·Anders Frid, Michael A. Nauck, Kasper Hermansen, Nehal Shah, Tsvetalina Tankova, Ismail Mitha, Maria Düring, Milan Zdravković, Matthews Dr	2008	3
20	Naxitamab-related adverse events within and across treatment cycles in patients with relapsed/refractory (R/R) high-risk neuroblastoma. Journal of Clinical Oncology ·Jaume Mora, Godfrey Chi Fung Chan, Daniel A. Morgenstern, Loredana Amoroso, Karsten Nysom, Joerg Faber, Arthur Wingerter, Melissa Bear, Alba Rubio‐San‐Simón, James Eldridge, Karen Tornøe, Maria Düring, Brian H. Kushner	2024	2

About Maria Düring

Maria Düring is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Neurology and Oncology, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Diabetes Treatment and Management (8 papers), Metabolism, Diabetes, and Cancer (7 papers), Breast Lesions and Carcinomas (6 papers), Global Cancer Incidence and Screening (4 papers), Breast Implant and Reconstruction (4 papers), Pancreatic function and diabetes (3 papers) and Neuroblastoma Research and Treatments (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Cancer Research (395 citations), Pharmacology (377 citations), Surgery (643 citations) and Oncology (384 citations). Maria Düring has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Kjeld Hermansen, Michael A. Nauck, Anders Frid, David R. Matthews, Tsvetalina Tankova, Ismail Mitha, Nalini S. Shah, Milan Zdravković, Henning T. Mouridsen and Susanne Möller. Their work appears in journals such as Diabetes Obesity and Metabolism, Journal of Clinical Oncology, Canadian Journal of Diabetes, British Journal of Cancer and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact